Cantor Fitzgerald Reiterates Overweight on Trulieve Cannabis, Maintains $15 Price Target

Benzinga · 2d ago
Cantor Fitzgerald analyst Gabie Ingoglia reiterates Trulieve Cannabis (NYSE:TRLV) with a Overweight and maintains $15 price target.